LAILA HANSEN: Open Payments
NPI 1295482651 · MELBOURNE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,030 in 44 payments from 9 companies in 2025. Trend: 2023 $495 · 2024 $149 · 2025 $1,030
Food & beverage: $1,030
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 9 | $277 |
| ABBVIE INC. | 7 | $145 |
| E.R. Squibb & Sons, L.L.C. | 6 | $135 |
| Alkermes, Inc. | 5 | $108 |
| Janssen Pharmaceuticals, Inc | 5 | $107 |
| Axsome Therapeutics, Inc. | 4 | $94 |
| Otsuka America Pharmaceutical, Inc. | 3 | $71 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $60 |
| Vanda Pharmaceuticals Inc. | 2 | $33 |
Products named: INGREZZA, VRAYLAR, COBENFY, INVEGA SUSTENNA, Auvelity, ARISTADA, CAPLYTA, ABILIFY MAINTENA.
Industry payments across FL — which companies pay providers there.
